6541.TW
Price:
$55.2
Market Cap:
$13.17B
Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar in Taiwan and the United States. The company focuses on delivering biosimilars which target neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. Its products pipeline includes TX01 and TX-05 which have completed Phase III clinical trials; TX-04 and TX-16 that are in Phase I clinical trial; and TX-52 and other products which are in pre-clinical trial. The company was formerly known as Ruenvex Biotech, Inc. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands.
Industry
Biotechnology
IPO Date
2015-08-13
Stock Exchange
TAI
Ticker
6541.TW
According to Tanvex BioPharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -7.01. This represents a change of -5.07% compared to the average of -7.38 of the last 4 quarters.
The mean historical PE Ratio of Tanvex BioPharma, Inc. over the last ten years is -12.07. The current -7.01 PE Ratio has changed 5.71% with respect to the historical average. Over the past ten years (40 quarters), 6541.TW's PE Ratio was at its highest in in the March 2020 quarter at -3.07. The PE Ratio was at its lowest in in the December 2016 quarter at -48.00.
Average
-12.07
Median
-7.43
Minimum
-39.10
Maximum
-3.93
Discovering the peaks and valleys of Tanvex BioPharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 156.99%
Maximum Annual PE Ratio = -3.93
Minimum Annual Increase = -57.74%
Minimum Annual PE Ratio = -39.10
Year | PE Ratio | Change |
---|---|---|
2024 | -7.33 | 86.59% |
2023 | -3.93 | -47.93% |
2022 | -7.54 | -38.47% |
2021 | -12.25 | 156.99% |
2020 | -4.77 | -1.32% |
2019 | -4.83 | -30.51% |
2018 | -6.95 | -31.22% |
2017 | -10.11 | -57.74% |
2016 | -23.92 | -38.82% |
2015 | -39.10 | 51.75% |
The current PE Ratio of Tanvex BioPharma, Inc. (6541.TW) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-6.26
5-year avg
-7.16
10-year avg
-12.07
Tanvex BioPharma, Inc.’s PE Ratio is greater than Adimmune Corporation (-33.69), less than Panion & Bf Biotech Inc. (60.13), less than OBI Pharma, Inc. (-4.29), less than Lotus Pharmaceutical Co., Ltd. (10.78), greater than TaiMed Biologics Inc. (-107.71),
Company | PE Ratio | Market cap |
---|---|---|
-33.69 | $8.18B | |
60.13 | $6.57B | |
-4.29 | $9.89B | |
10.78 | $59.57B | |
-107.71 | $21.71B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tanvex BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tanvex BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Tanvex BioPharma, Inc.'s PE Ratio?
How is the PE Ratio calculated for Tanvex BioPharma, Inc. (6541.TW)?
What is the highest PE Ratio for Tanvex BioPharma, Inc. (6541.TW)?
What is the 3-year average PE Ratio for Tanvex BioPharma, Inc. (6541.TW)?
What is the 5-year average PE Ratio for Tanvex BioPharma, Inc. (6541.TW)?
How does the current PE Ratio for Tanvex BioPharma, Inc. (6541.TW) compare to its historical average?